| Dr Evangeline V Dacanay, MD | |
|
800 West Maple Street, Medical Lake, WA 99022-0800 | |
| (509) 299-3121 | |
| (509) 299-7015 |
| Full Name | Dr Evangeline V Dacanay |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 46 Years |
| Location | 800 West Maple Street, Medical Lake, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154303428 | NPI | - | NPPES |
| 1020843 | Medicaid | WA | |
| 8131823 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD00028755 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Department Of Social Dept Of Shs Div Of Instns | 9133013725 | 22 |
News Archive
A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time-a tool that could someday help public health officials combat misinformation online.
Opponents of the tax, which helps fund the health law, have proposed killing it to help defuse the current standoff, but there is not yet consensus on that effort.
Epidemiologist David Van Sickle spent years studying asthma, but like many researchers of the chronic disease, he was frustrated by the obstacles to determining precise triggers of an individual attack. That frustration gave him an idea for a rescue inhaler topped with a GPS sensor.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.
› Verified 8 days ago
| Entity Name | Department Of Social Dept Of Shs Div Of Instns |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467440602 PECOS PAC ID: 9133013725 Enrollment ID: O20040213000028 |
News Archive
A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time-a tool that could someday help public health officials combat misinformation online.
Opponents of the tax, which helps fund the health law, have proposed killing it to help defuse the current standoff, but there is not yet consensus on that effort.
Epidemiologist David Van Sickle spent years studying asthma, but like many researchers of the chronic disease, he was frustrated by the obstacles to determining precise triggers of an individual attack. That frustration gave him an idea for a rescue inhaler topped with a GPS sensor.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.
› Verified 8 days ago
| Entity Name | Spokane Behavioral Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932698107 PECOS PAC ID: 2961757489 Enrollment ID: O20190117001282 |
News Archive
A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time-a tool that could someday help public health officials combat misinformation online.
Opponents of the tax, which helps fund the health law, have proposed killing it to help defuse the current standoff, but there is not yet consensus on that effort.
Epidemiologist David Van Sickle spent years studying asthma, but like many researchers of the chronic disease, he was frustrated by the obstacles to determining precise triggers of an individual attack. That frustration gave him an idea for a rescue inhaler topped with a GPS sensor.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evangeline V Dacanay, MD 107 S Division St, Spokane, WA 99202-1510 Ph: (509) 838-4651 | Dr Evangeline V Dacanay, MD 800 West Maple Street, Medical Lake, WA 99022-0800 Ph: (509) 299-3121 |
News Archive
A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time-a tool that could someday help public health officials combat misinformation online.
Opponents of the tax, which helps fund the health law, have proposed killing it to help defuse the current standoff, but there is not yet consensus on that effort.
Epidemiologist David Van Sickle spent years studying asthma, but like many researchers of the chronic disease, he was frustrated by the obstacles to determining precise triggers of an individual attack. That frustration gave him an idea for a rescue inhaler topped with a GPS sensor.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies.
› Verified 8 days ago
Laura J. Baehner, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Maple Street, Medical Lake, WA 99022 Phone: 509-565-4000 Fax: 509-565-4705 | |
Dr. Samaya Cassandra Lovegood, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Maple Street, Medical Lake, WA 99022 Phone: 509-565-4000 Fax: 509-565-4705 | |
Dr. Averly H Nelson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 850 Maple Street, Eastern State Hospital, Medical Lake, WA 99022 Phone: 509-565-4000 Fax: 509-565-4705 | |
Dr. Muneeb Malik, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 W Maple St, Medical Lake, WA 99022 Phone: 509-565-4000 | |
Dr. Lesley M. Blake, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 850 Maple Street, Medical Lake, WA 99022 Phone: 509-299-3121 Fax: 509-299-7015 | |
Marion Fossum, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1717 S Ritchey Rd, Medical Lake, WA 99022 Phone: 509-590-8766 |